Avalon GloboCare Corp. (ALBT)
NASDAQ: ALBT · Real-Time Price · USD
3.130
-0.200 (-6.01%)
At close: Oct 31, 2024, 4:00 PM
3.150
+0.020 (0.64%)
After-hours: Oct 31, 2024, 7:24 PM EDT
Avalon GloboCare Revenue
Avalon GloboCare had revenue of $-1.45K in the quarter ending June 30, 2024, a decrease of -100.35%. This brings the company's revenue in the last twelve months to $-7.53M, down -719.79% year-over-year. In the year 2023, Avalon GloboCare had annual revenue of $-7.33M, down -732.09%.
Revenue (ttm)
$-7.53M
Revenue Growth
-719.79%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
3.34M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Ashford Hospitality Trust | 1.28B |
Wheeler Real Estate Investment Trust | 103.17M |
Ucommune International | 42.47M |
Presidio Property Trust | 18.35M |
Power REIT | 2.19M |
Gaucho Group Holdings | 2.01M |
New Concept Energy | 145.00K |
ALBT News
- 6 days ago - Avalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving - GlobeNewsWire
- 3 months ago - Avalon's Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction - GlobeNewsWire
- 5 months ago - Avalon GloboCare Receives Notice from Nasdaq Regarding Delayed Quarterly Report - GlobeNewsWire
- 6 months ago - Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference - GlobeNewsWire
- 7 months ago - Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union - GlobeNewsWire
- 11 months ago - Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US - GlobeNewsWire
- 1 year ago - Apple Approves Use of Avalon GloboCare's KetoAir Mobile Application - GlobeNewsWire
- 1 year ago - Avalon's Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter Device - GlobeNewsWire